<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38405190</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Perturbations in gut and respiratory microbiota in COVID-19 and influenza patients: a systematic review and meta-analysis.</ArticleTitle><Pagination><StartPage>1301312</StartPage><MedlinePgn>1301312</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1301312</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2024.1301312</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">Coronavirus disease-19 (COVID-19)/influenza poses unprecedented challenges to the global economy and healthcare services. Numerous studies have described alterations in the microbiome of COVID-19/influenza patients, but further investigation is needed to understand the relationship between the microbiome and these diseases. Herein, through systematic comparison between COVID-19 patients, long COVID-19 patients, influenza patients, no COVID-19/influenza controls and no COVID-19/influenza patients, we conducted a comprehensive review to describe the microbial change of respiratory tract/digestive tract in COVID-19/influenza patients.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We systematically reviewed relevant literature by searching the PubMed, Embase, and Cochrane Library databases from inception to August 12, 2023. We conducted a comprehensive review to explore microbial alterations in patients with COVID-19/influenza. In addition, the data on &#x3b1;-diversity were summarized and analyzed by meta-analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 134 studies comparing COVID-19 patients with controls and 18 studies comparing influenza patients with controls were included. The Shannon indices of the gut and respiratory tract microbiome were slightly decreased in COVID-19/influenza patients compared to no COVID-19/influenza controls. Meanwhile, COVID-19 patients with more severe symptoms also exhibited a lower Shannon index versus COVID-19 patients with milder symptoms. The intestinal microbiome of COVID-19 patients was characterized by elevated opportunistic pathogens along with reduced short-chain fatty acid (SCFAs)-producing microbiota. Moreover, Enterobacteriaceae (including <i>Escherichia</i> and <i>Enterococcus</i>) and <i>Lactococcus</i>, were enriched in the gut and respiratory tract of COVID-19 patients. Conversely, Haemophilus and Neisseria showed reduced abundance in the respiratory tract of both COVID-19 and influenza patients.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">In this systematic review, we identified the microbiome in COVID-19/influenza patients in comparison with controls. The microbial changes in influenza and COVID-19 are partly similar.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Chu, Song, Zhou, Chen, Chu, Li, Li, Liu, Hou, Wu and Gong.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Chu</LastName><ForeName>Xiu-Jie</ForeName><Initials>XJ</Initials><AffiliationInfo><Affiliation>Department of Acute Infectious Disease Prevention and Control, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Song</LastName><ForeName>Dan-Dan</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Department of Acute Infectious Disease Prevention and Control, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhou</LastName><ForeName>Ming-Hua</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiu-Zhi</ForeName><Initials>XZ</Initials><AffiliationInfo><Affiliation>Department of Acute Infectious Disease Prevention and Control, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chu</LastName><ForeName>Na</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Acute Infectious Disease Prevention and Control, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Acute Infectious Disease Prevention and Control, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Bao-Zhu</ForeName><Initials>BZ</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Song-Hui</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>School of Public Health, Bengbu Medical College, Bengbu, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Sai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Acute Infectious Disease Prevention and Control, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jia-Bing</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Acute Infectious Disease Prevention and Control, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Lei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Acute Infectious Disease Prevention and Control, Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">gut</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">microbiome</Keyword><Keyword MajorTopicYN="N">respiratory tract</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>26</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>26</Day><Hour>4</Hour><Minute>40</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38405190</ArticleId><ArticleId IdType="pmc">PMC10884097</ArticleId><ArticleId IdType="doi">10.3389/fmed.2024.1301312</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mcgowan VJ, Bambra C. COVID-19 mortality and deprivation: pandemic, syndemic, and endemic health inequalities. Lancet Public Health. (2022) 7:E966&#x2013;75. doi: 10.1016/S2468-2667(22)00223-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(22)00223-7</ArticleId><ArticleId IdType="pmc">PMC9629845</ArticleId><ArticleId IdType="pubmed">36334610</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. (2020) 395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y, Liu P, Shi XL, Chu YL, Zhang J, Xia J, et al. . SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut. (2020) 69:1143&#x2013;4. doi: 10.1136/gutjnl-2020-320891, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-320891</ArticleId><ArticleId IdType="pubmed">32139552</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Sun KY, Meng TQ, Ye Z, Guo SM, Li ZM, et al. . Gut microbiota may not be fully restored in recovered COVID-19 patients after 3-month recovery. Front Nutr. (2021) 8:638825. doi: 10.3389/fnut.2021.638825, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.638825</ArticleId><ArticleId IdType="pmc">PMC8155354</ArticleId><ArticleId IdType="pubmed">34055851</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao XH, Guo Q, Wu JB, Gong L, Chen F, Hou S, et al. . Clinical and epidemiological characteristics of 47 minor cases with COVID-19 in Anhui Province in 2020 [J]. Anhui J Prev Med. (2021) 27:386&#x2013;9. doi: 10.19837/j.cnki.ahyf.2021.05.014</Citation><ArticleIdList><ArticleId IdType="doi">10.19837/j.cnki.ahyf.2021.05.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. . Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. (2020) 323:1061&#x2013;9. doi: 10.1001/jama.2020.1585, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>The Human Microbiome Project Consortium . Structure, function and diversity of the healthy human microbiome. Nature. (2012) 486:207&#x2013;14. doi: 10.1038/nature11234</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11234</ArticleId><ArticleId IdType="pmc">PMC3564958</ArticleId><ArticleId IdType="pubmed">22699609</ArticleId></ArticleIdList></Reference><Reference><Citation>Dominguez-Bello MG, Godoy-Vitorino F, Knight R, Blaser MJ. Role of the microbiome in human development. Gut. (2019) 68:1108&#x2013;14. doi: 10.1136/gutjnl-2018-317503, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2018-317503</ArticleId><ArticleId IdType="pmc">PMC6580755</ArticleId><ArticleId IdType="pubmed">30670574</ArticleId></ArticleIdList></Reference><Reference><Citation>Young VB. The role of the microbiome in human health and disease: an introduction for clinicians. BMJ. (2017) 356:J831. doi: 10.1136/bmj.j831</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j831</ArticleId><ArticleId IdType="pubmed">28298355</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang R, Gomez Castro MF, Mccune BT, Zeng Q, Rothlauf PW, Sonnek NM, et al. . Tmprss2 and Tmprss4 promote SARS-CoV-2 infection of human small intestinal enterocytes. Sci Immunol. (2020) 5:eabc3582. doi: 10.1126/sciimmunol.abc3582, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abc3582</ArticleId><ArticleId IdType="pmc">PMC7285829</ArticleId><ArticleId IdType="pubmed">32404436</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, et al. . SARS-CoV-2 receptor Ace2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell. (2020) 181:1016&#x2013;1035.e19. doi: 10.1016/j.cell.2020.04.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.035</ArticleId><ArticleId IdType="pmc">PMC7252096</ArticleId><ArticleId IdType="pubmed">32413319</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L, et al. . Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1n1 influenza. Clin Infect Dis. (2020) 71:2669&#x2013;78. doi: 10.1093/cid/ciaa709, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa709</ArticleId><ArticleId IdType="pmc">PMC7314193</ArticleId><ArticleId IdType="pubmed">32497191</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S, Zhang F, Zhou F, Li H, Ge W, Gan R, et al. . Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19. Signal Transduct Target Ther. (2021) 6:191. doi: 10.1038/s41392-021-00614-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00614-3</ArticleId><ArticleId IdType="pmc">PMC8116522</ArticleId><ArticleId IdType="pubmed">33986253</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Cheng X, Jiang G, Tang H, Ming S, Tang L, et al. . Altered oral and gut microbiota and its association with SARS-CoV-2 viral load in COVID-19 patients during hospitalization. NPJ Biofilms Microbiomes. (2021) 7:61. doi: 10.1038/s41522-021-00232-5, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41522-021-00232-5</ArticleId><ArticleId IdType="pmc">PMC8298611</ArticleId><ArticleId IdType="pubmed">34294722</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. (2014) 14:135. doi: 10.1186/1471-2288-14-135, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2288-14-135</ArticleId><ArticleId IdType="pmc">PMC4383202</ArticleId><ArticleId IdType="pubmed">25524443</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Wei J, Zhang W, Doherty M, Zhang Y, Xie H, et al. . Gut dysbiosis in rheumatic diseases: a systematic review and meta-analysis of 92 observational studies. EBioMedicine. (2022) 80:104055. doi: 10.1016/j.ebiom.2022.104055, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104055</ArticleId><ArticleId IdType="pmc">PMC9120231</ArticleId><ArticleId IdType="pubmed">35594658</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng X, Zhang Y, Li Y, Wu Q, Wu J, Park SK, et al. . Meta-analysis of 16s rRNA microbial data identified alterations of the gut microbiota in COVID-19 patients during the acute and recovery phases. BMC Microbiol. (2022) 22:274. doi: 10.1186/s12866-022-02686-9, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12866-022-02686-9</ArticleId><ArticleId IdType="pmc">PMC9662111</ArticleId><ArticleId IdType="pubmed">36376804</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan L, Zhong MM, Liu Q, Chen Y, Zhao YQ, Zhao J, et al. . Potential interaction between the oral microbiota and COVID-19: a meta-analysis and bioinformatics prediction. Front Cell Infect Microbiol. (2023) 13:1193340. doi: 10.3389/fcimb.2023.1193340, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1193340</ArticleId><ArticleId IdType="pmc">PMC10282655</ArticleId><ArticleId IdType="pubmed">37351182</ArticleId></ArticleIdList></Reference><Reference><Citation>Rattanaburi S, Sawaswong V, Chitcharoen S, Sivapornnukul P, Nimsamer P, Suntronwong N, et al. . Bacterial microbiota in upper respiratory tract of COVID-19 and influenza patients. Exp Biol Med. (2022) 247:409&#x2013;15. doi: 10.1177/15353702211057473</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/15353702211057473</ArticleId><ArticleId IdType="pmc">PMC8919321</ArticleId><ArticleId IdType="pubmed">34775842</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzanares-Meza LD, Medina-Contreras O. SARS-CoV-2 and influenza: a comparative overview and treatment implications. Bol Med Hosp Infant Mex. (2020) 77:262&#x2013;73. doi: 10.24875/BMHIM.20000183, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.24875/BMHIM.20000183</ArticleId><ArticleId IdType="pubmed">33064680</ArticleId></ArticleIdList></Reference><Reference><Citation>Piroth L, Cottenet J, Mariet AS, Bonniaud P, Blot M, Tubert-Bitter P, et al. . Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med. (2021) 9:251&#x2013;9. doi: 10.1016/S2213-2600(20)30527-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30527-0</ArticleId><ArticleId IdType="pmc">PMC7832247</ArticleId><ArticleId IdType="pubmed">33341155</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, et al. . Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. (2021) 76:428&#x2013;55. doi: 10.1111/all.14657</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14657</ArticleId><ArticleId IdType="pubmed">33185910</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan CA, Garrett WS. Fusobacterium Nucleatum - symbiont, opportunist and oncobacterium. Nat Rev Microbiol. (2019) 17:156&#x2013;66. doi: 10.1038/s41579-018-0129-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0129-6</ArticleId><ArticleId IdType="pmc">PMC6589823</ArticleId><ArticleId IdType="pubmed">30546113</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X, Guthrie BGH, Alexander M, Noecker C, Ramirez L, Glasser NR, et al. . Genetic manipulation of the human gut bacterium Eggerthella Lenta reveals a widespread family of transcriptional regulators. Nat Commun. (2022) 13:7624. doi: 10.1038/s41467-022-33576-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33576-3</ArticleId><ArticleId IdType="pmc">PMC9734109</ArticleId><ArticleId IdType="pubmed">36494336</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong X, Tian S, Yang P, Lebreton F, Bao H, Sheng K, et al. . Emerging Enterococcus pore-forming toxins with MHC/HLA-I as receptors. Cell. (2022) 185:1157&#x2013;1171.e22. doi: 10.1016/j.cell.2022.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.02.002</ArticleId><ArticleId IdType="pmc">PMC8978092</ArticleId><ArticleId IdType="pubmed">35259335</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivi&#xe8;re A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and butyrate-producing Colon Bacteria: importance and strategies for their stimulation in the human gut. Front Microbiol. (2016) 7:979. doi: 10.3389/fmicb.2016.00979</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.00979</ArticleId><ArticleId IdType="pmc">PMC4923077</ArticleId><ArticleId IdType="pubmed">27446020</ArticleId></ArticleIdList></Reference><Reference><Citation>Vital M, Karch A, Pieper DH. Colonic butyrate-producing communities in humans: an overview using omics data. Msystems. (2017) 2:e00130-17. doi: 10.1128/mSystems.00130-17, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mSystems.00130-17</ArticleId><ArticleId IdType="pmc">PMC5715108</ArticleId><ArticleId IdType="pubmed">29238752</ArticleId></ArticleIdList></Reference><Reference><Citation>Llamas MA, Imperi F, Visca P, Lamont IL. Cell-surface signaling in pseudomonas: stress responses, Iron transport, and pathogenicity. FEMS Microbiol Rev. (2014) 38:569&#x2013;97. doi: 10.1111/1574-6976.12078, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1574-6976.12078</ArticleId><ArticleId IdType="pubmed">24923658</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen M, Johansson D, S&#xf6;birk SK, M&#xf6;rgelin M, Shannon O. Clinical isolates of Enterococcus Faecalis aggregate human platelets. Microbes Infect. (2010) 12:295&#x2013;301. doi: 10.1016/j.micinf.2010.01.005, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2010.01.005</ArticleId><ArticleId IdType="pubmed">20109578</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Zhang W, Guo M, Xiao C, Fu Z, Yu S, et al. . Integrated analysis of gut microbiome and host immune responses in COVID-19. Front Med. (2022) 16:263&#x2013;75. doi: 10.1007/s11684-022-0921-6, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-022-0921-6</ArticleId><ArticleId IdType="pmc">PMC8902486</ArticleId><ArticleId IdType="pubmed">35258762</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Tyne D, Gilmore MS. Friend turned foe: evolution of Enterococcal virulence and antibiotic resistance. Annu Rev Microbiol. (2014) 68:337&#x2013;56. doi: 10.1146/annurev-micro-091213-113003, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-micro-091213-113003</ArticleId><ArticleId IdType="pmc">PMC4384341</ArticleId><ArticleId IdType="pubmed">25002090</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang F, Wan Y, Zuo T, Yeoh YK, Liu Q, Zhang L, et al. . Prolonged impairment of short-chain fatty acid and L-isoleucine biosynthesis in gut microbiome in patients with COVID-19. Gastroenterology. (2022) 162:548&#x2013;561.e4. doi: 10.1053/j.gastro.2021.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.10.013</ArticleId><ArticleId IdType="pmc">PMC8529231</ArticleId><ArticleId IdType="pubmed">34687739</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu XJ, Cao NW, Zhou HY, Meng X, Guo B, Zhang HY, et al. . The oral and gut microbiome in rheumatoid arthritis patients: a systematic review. Rheumatology. (2021) 60:1054&#x2013;66. doi: 10.1093/rheumatology/keaa835, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa835</ArticleId><ArticleId IdType="pubmed">33450018</ArticleId></ArticleIdList></Reference><Reference><Citation>Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, et al. . A decrease of the butyrate-producing species Roseburia Hominis and Faecalibacterium Prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. (2014) 63:1275&#x2013;83. doi: 10.1136/gutjnl-2013-304833, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2013-304833</ArticleId><ArticleId IdType="pubmed">24021287</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanada K, Nakajima S, Kurokawa S, Barcel&#xf3;-Soler A, Ikuse D, Hirata A, et al. . Gut microbiota and major depressive disorder: a systematic review and meta-analysis. J Affect Disord. (2020) 266:1&#x2013;13. doi: 10.1016/j.jad.2020.01.102, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.01.102</ArticleId><ArticleId IdType="pubmed">32056863</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xf8;rskov-Lauritsen N. Classification, identification, and clinical significance of Haemophilus and Aggregatibacter species with host specificity for humans. Clin Microbiol Rev. (2014) 27:214&#x2013;40. doi: 10.1128/CMR.00103-13, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00103-13</ArticleId><ArticleId IdType="pmc">PMC3993099</ArticleId><ArticleId IdType="pubmed">24696434</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallstr&#xf6;m T, Riesbeck K. Haemophilus influenzae and the complement system. Trends Microbiol. (2010) 18:258&#x2013;65. doi: 10.1016/j.tim.2010.03.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2010.03.007</ArticleId><ArticleId IdType="pubmed">20399102</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson RP, Huffnagle GB. The lung microbiome: new principles for respiratory bacteriology in health and disease. PLoS Pathog. (2015) 11:E1004923. doi: 10.1371/journal.ppat.1004923, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004923</ArticleId><ArticleId IdType="pmc">PMC4497592</ArticleId><ArticleId IdType="pubmed">26158874</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal LN, Clemente JC, Tsay JC, Koralov SB, Keller BC, Wu BG, et al. . Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat Microbiol. (2016) 1:16031. doi: 10.1038/nmicrobiol.2016.31, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmicrobiol.2016.31</ArticleId><ArticleId IdType="pmc">PMC5010013</ArticleId><ArticleId IdType="pubmed">27572644</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahamsson TR, Jakobsson HE, Andersson AF, Bj&#xf6;rkst&#xe9;n B, Engstrand L, Jenmalm MC. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy. (2014) 44:842&#x2013;50. doi: 10.1111/cea.12253, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cea.12253</ArticleId><ArticleId IdType="pubmed">24330256</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson RP, Singer BH, Newstead MW, Falkowski NR, Erb-Downward JR, Standiford TJ, et al. . Enrichment of the lung microbiome with gut Bacteria in Sepsis and the acute respiratory distress syndrome. Nat Microbiol. (2016) 1:16113. doi: 10.1038/nmicrobiol.2016.113, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmicrobiol.2016.113</ArticleId><ArticleId IdType="pmc">PMC5076472</ArticleId><ArticleId IdType="pubmed">27670109</ArticleId></ArticleIdList></Reference><Reference><Citation>Bingula R, Filaire M, Radosevic-Robin N, Bey M, Berthon JY, Bernalier-Donadille A, et al. . Desired turbulence? Gut-lung axis, immunity, and lung cancer. J Oncol. (2017) 2017:5035371. doi: 10.1155/2017/5035371</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/5035371</ArticleId><ArticleId IdType="pmc">PMC5623803</ArticleId><ArticleId IdType="pubmed">29075294</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsland BJ, Trompette A, Gollwitzer ES. The gut-lung axis in respiratory disease. Ann Am Thorac Soc. (2015) 12:S150&#x2013;6. doi: 10.1513/AnnalsATS.201503-133AW</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201503-133AW</ArticleId><ArticleId IdType="pubmed">26595731</ArticleId></ArticleIdList></Reference><Reference><Citation>Ver Heul A, Planer J, Kau AL. The human microbiota and asthma. Clin Rev Allergy Immunol. (2019) 57:350&#x2013;63. doi: 10.1007/s12016-018-8719-7, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-018-8719-7</ArticleId><ArticleId IdType="pmc">PMC7449604</ArticleId><ArticleId IdType="pubmed">30426401</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelly D, Conway S, Aminov R. Commensal gut bacteria: mechanisms of immune modulation. Trends Immunol. (2005) 26:326&#x2013;33. doi: 10.1016/j.it.2005.04.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2005.04.008</ArticleId><ArticleId IdType="pubmed">15922949</ArticleId></ArticleIdList></Reference><Reference><Citation>Tappenden KA, Deutsch AS. The physiological relevance of the intestinal microbiota &#x2013; contributions to human health. J Am Coll Nutr. (2007) 26:679S&#x2013;83S. doi: 10.1080/07315724.2007.10719647</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07315724.2007.10719647</ArticleId><ArticleId IdType="pubmed">18187433</ArticleId></ArticleIdList></Reference><Reference><Citation>Kircheis R, Haasbach E, Lueftenegger D, Heyken WT, Ocker M, Planz O. Nf-&#x39a;b pathway as a potential target for treatment of critical stage COVID-19 patients. Front Immunol. (2020) 11:598444. doi: 10.3389/fimmu.2020.598444, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.598444</ArticleId><ArticleId IdType="pmc">PMC7759159</ArticleId><ArticleId IdType="pubmed">33362782</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheson NJ, Lehner PJ. How does SARS-CoV-2 cause COVID-19? Science. (2020) 369:510&#x2013;1. doi: 10.1126/science.abc6156</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6156</ArticleId><ArticleId IdType="pubmed">32732413</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. (2020) 20:355&#x2013;62. doi: 10.1038/s41577-020-0331-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Luo R, Wang Y, Deng P, Song T, Zhang M, et al. . SARS-CoV-2 induced intestinal responses with a biomimetic human gut-on-chip. Sci Bull. (2021) 66:783&#x2013;93. doi: 10.1016/j.scib.2020.11.015, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scib.2020.11.015</ArticleId><ArticleId IdType="pmc">PMC7704334</ArticleId><ArticleId IdType="pubmed">33282445</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>